Allergy Immunotherapy for the Reduction of Asthma Read more about Allergy Immunotherapy for the Reduction of Asthma
New Onset Type 1 Diabetes: Role of Exenatide Read more about New Onset Type 1 Diabetes: Role of Exenatide
A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002) Read more about A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)
Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza Read more about Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza
Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum, Phase 2 Read more about Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum, Phase 2
SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence Read more about SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241) Read more about A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241)
Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis Read more about Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis
Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia Read more about Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia
A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist Read more about A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist